Drug Type Small molecule drug |
Synonyms- |
Mechanism PARP-7 inhibitors(TCDD-inducible poly [ADP-ribose] polymerase inhibitors), PARP10 inhibitors(poly(ADP-ribose) polymerase family member 10 inhibitors), PARP11 inhibitors(poly(ADP-ribose) polymerase family member 11 inhibitors) + [2] |
Therapeutic Areas |
Active Indication |
Inactive Indication- |
Originator Organization |
Active Organization |
Inactive Organization- |
Drug Highest PhasePreclinical |
First Approval Date- |
Regulation- |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Neoplasms | Preclinical | FI | 04 Jan 2023 |